1 not yet recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 1, Withdrawn 1 |
| Phase 2 | 2 | Not yet recruiting 1, Withdrawn 1 |
Follow Advanced Triple-Negative Breast Cancer: new trials by email Literature Review of Advanced Triple-Negative Breast Cancer trials Research Report on Advanced Triple-Negative Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC) Zn-Telomir - Triple-Negative Breast Cancer (TNBC), Advanced Triple-Negative Breast Cancer | Phase 1 / Phase 2 | Not yet recruiting | Telomir Pharmaceuticals, Inc. | 76 | 2026-10-01 | 2026-06-23 |
| A First-in-man Phase I/II Study of Oral ONC201 in Patients With Advanced Cancer ONC201 - Advanced Glioblastoma, Advanced Colorectal Cancer | Phase 1 / Phase 2 | Withdrawn | Jazz Pharmaceuticals | 2014-01-01 | 2021-04-30 |
Breast Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Breast Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
TIC10 compound (1)
Jazz Pharmaceuticals (1) · Telomir Pharmaceuticals, Inc. (1)
United States (1)
Jason Faris, MD (1)